<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(15)</volume><submitter>Wang Y</submitter><pubmed_abstract>&lt;b>Rationale:&lt;/b> Hyperactivation of Hippo-Yes-associated protein (YAP) signaling pathway governs tumorigenesis of gastric cancer (GC). Here we reveal that minichromosome maintenance complex component 6 (MCM6) is a critical transcriptional target of YAP in GC. We aim to investigate the function, mechanism of action, and clinical implication of MCM6 in GC. &lt;b>Methods:&lt;/b> The downstream targets of YAP were screened by RNA sequencing (RNA-seq) and microarray, and further validated by chromatin immunoprecipitation PCR and luciferase reporter assays. The clinical implication of MCM6 was assessed in multiple GC cohorts. Biological function of MCM6 was evaluated &lt;i>in vitro&lt;/i>, in patient-derived organoids, and &lt;i>in vivo&lt;/i>. RNA-seq was performed to unravel downstream signaling of MCM6. Poten</pubmed_abstract><journal>Theranostics</journal><pagination>6509-6526</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9516235</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>MCM6 is a critical transcriptional target of YAP to promote gastric tumorigenesis and serves as a therapeutic target.</pubmed_title><pmcid>PMC9516235</pmcid><pubmed_authors>Wu WKK</pubmed_authors><pubmed_authors>Kang W</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Ma BBY</pubmed_authors><pubmed_authors>Lo KW</pubmed_authors><pubmed_authors>Wong CC</pubmed_authors><pubmed_authors>Chen H</pubmed_authors><pubmed_authors>Yu J</pubmed_authors><pubmed_authors>Chen B</pubmed_authors><pubmed_authors>Liu W</pubmed_authors><pubmed_authors>Zhou Z</pubmed_authors><pubmed_authors>To KF</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Cheung AHK</pubmed_authors><pubmed_authors>Liang L</pubmed_authors><pubmed_authors>Chan MWY</pubmed_authors><pubmed_authors>Cheng ASL</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Yan H</pubmed_authors></additional><is_claimable>false</is_claimable><name>MCM6 is a critical transcriptional target of YAP to promote gastric tumorigenesis and serves as a therapeutic target.</name><description>&lt;b>Rationale:&lt;/b> Hyperactivation of Hippo-Yes-associated protein (YAP) signaling pathway governs tumorigenesis of gastric cancer (GC). Here we reveal that minichromosome maintenance complex component 6 (MCM6) is a critical transcriptional target of YAP in GC. We aim to investigate the function, mechanism of action, and clinical implication of MCM6 in GC. &lt;b>Methods:&lt;/b> The downstream targets of YAP were screened by RNA sequencing (RNA-seq) and microarray, and further validated by chromatin immunoprecipitation PCR and luciferase reporter assays. The clinical implication of MCM6 was assessed in multiple GC cohorts. Biological function of MCM6 was evaluated &lt;i>in vitro&lt;/i>, in patient-derived organoids, and &lt;i>in vivo&lt;/i>. RNA-seq was performed to unravel downstream signaling of MCM6. Poten</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2026-05-31T15:56:46.352Z</modification><creation>2025-04-04T12:45:29.307Z</creation></dates><accession>S-EPMC9516235</accession><cross_references><pubmed>36185598</pubmed><doi>10.7150/thno.75431</doi></cross_references></HashMap>